RGNXREGENXBIO Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $8.80 (+5.16% today)

Market Cap: $440.26M

P/E (TTM): -2.30

Analyst Upside: 187.4%

Relative Strength (RS%): 97

-45.6% from 52-week high

Back to Scanner

RGNX

NASDAQRS 97Score 45

REGENXBIO Inc.

HealthcareBiotechnology$440.26M1 setup passing
$8.80
+5.2% ($0.44)
-45.6% from 52W High
P/E (TTM)
-2.30
Fwd P/E
PEG
Analyst Upside
+187.4%
EPS Growth
Gross Margin
52.9%
ROE
-103.1%
D/E
2.54
Div Yield
0.0%
Avg Volume
421.0K

Price Chart

Key Levels

SMA 200
$10.49
SMA 50
$9.41
Price
$8.80
52W High
$16.18
Target
$25.29

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst